Segment Information - Summary of Company's Financial Data for Development and Commercialization of Pharmaceutical Products Segment (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Segment Reporting Information [Line Items] | ||||
| Net product sales | $ 3,752,142 | $ 2,551,366 | $ 6,832,300 | $ 4,286,856 |
| Cost of goods sold | 167,679 | 41,478 | 209,292 | 134,007 |
| Eversana profit sharing | 5,134,902 | 3,733,450 | 9,432,407 | 6,872,986 |
| Interest income | 112,534 | 81,001 | 231,386 | 127,059 |
| Interest expense (non-cash) | 124,658 | 124,657 | 247,945 | 249,315 |
| Pharmaceutical Products [Member] | ||||
| Segment Reporting Information [Line Items] | ||||
| Net product sales | 3,752,142 | 2,551,366 | 6,832,300 | 4,286,856 |
| Cost of goods sold | (167,679) | (41,478) | (209,292) | (134,007) |
| Eversana profit sharing | (3,188,997) | (2,168,661) | (5,807,132) | (3,643,922) |
| Employee expenses | (631,795) | (561,171) | (1,269,894) | (1,257,973) |
| Professional fees | (927,215) | (624,038) | (1,631,844) | (1,127,755) |
| Stock-based compensation | (104,253) | (126,578) | (188,637) | (380,607) |
| Sales and marketing expenses | (172,885) | (203,294) | (361,553) | (367,091) |
| Other operating expenses | (118,170) | (49,708) | (224,543) | (100,283) |
| Interest income | 112,534 | 81,001 | 231,386 | 127,059 |
| Interest expense (non-cash) | (124,658) | (124,657) | (247,945) | (249,315) |
| Total segment costs loss and net loss | $ (1,570,976) | $ (1,267,218) | $ (2,877,154) | $ (2,847,038) |
| X | ||||||||||
- Definition Cost of goods sold expenses. No definition available.
|
| X | ||||||||||
- Definition Segment costs loss and net loss. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of selling and marketing expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|